IMMCO Diagnostics

Immco Diagnostics incorporates innovative medical devices, diagnostic laboratory testing expertise and pioneering research for a comprehensive solution to autoimmune disease diagnostics.

The company offers industry leading autoimmune disease diagnostics under the ImmuGlo™ (immunofluoresence assays), ImmuLisa™ (enzyme linked immunosorbent assays), and ImmuBlot™ (Western blot assays) brands.

Since 1971, autoimmunity has been Immco's focus. Supported by extensive research and a proven track record of accuracy and reliability, the company has expanded from a specialized reference lab into an international organization offering high quality diagnostic products and services for the detection and diagnosis of autoimmune diseases to support improved patient care and prognosis.

The Product division supplies leading in vitro diagnostic assays and reagents to laboratories worldwide. Immco Reference Laboratory offers biopsy, serology and other test services for diagnosis of autoimmune disorders and related immunological conditions.

Immco researchers work closely with industry experts in development of proprietary products. This has led to innovations such as the first commercial assay for detection of endomysial antibodies associated with celiac disease and the first panel of autoimmune hearing loss diagnostics, including the hsp-70 antibody OtoBlot™.

Search for products by IMMCO Diagnostics

IMMCO Diagnostics products by Product Category

• 
  All Products